Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
1,287 total articles
Terilyn J. Monroe, Chief People Officer of Guardant Health, divested 8,571 shares valued at approximately $977,900 on January 21, 2026, amid a backdrop of encouraging FDA approval and positive analyst sentiment. The transactions occurred at prices ranging from $112.34 to $115.70 per share. Guardant Health has recently achieved FDA clearance for its…
MediaAlpha, Inc. director Yi Steven sold 24,000 shares over three days, accumulating proceeds close to $267,432. The sales coincided with the company’s strong financial performance in Q3 2025, prompting increased analyst price targets and corporate governance updates including board changes and bylaw amendments.
Joseph P. Lyssikatos, Chief Scientific Officer at Enliven Therapeutics, executed stock sales totaling $535,098 through a pre-set trading plan, amidst the company's strong share performance and encouraging clinical trial updates for its chronic myeloid leukemia treatment. These transactions, reported in a recent SEC filing, reflect ongoing insider a…
Enliven Therapeutics director Richard A. Heyman completed a sale of 1,230 shares of company stock for approximately $32,901 under a pre-arranged trading plan. Concurrently, the company revealed encouraging Phase 1b clinical trial outcomes for its chronic myeloid leukemia drug candidate ELVN-001 and announced significant governance updates including…
Sanjit Biswas, CEO and Director of Samsara Inc, liquidated approximately $8.5 million worth of Class A Common Stock via two separate 10b5-1 trading plans on January 20, 2026. This sale occurred against the backdrop of a 33.49% year-over-year decline in Samsara's stock price, which currently trades near its 52-week low. Despite the share divestment,…
Adam Eltoukhy, Samsara Inc.'s Executive Vice President, Chief Legal Officer, and Secretary, executed stock sales totaling 4,688 Class A shares, amounting to approximately $152,563 on January 20, 2026. Samsara's stock traded close to its 52-week low amid ongoing safety performance highlights and favorable analyst coverage.
Bulldog Investors, LLP, along with partners Phillip Goldstein and Andrew Dakos, sold 678 shares of the MFS High Yield Municipal Trust at $3.5 per share, totaling $2,373 on January 20, 2026. The fund currently trades close to its yearly peak with a strong dividend history. This move adjusts holdings among management but maintains significant direct …
Randall K. Fields, CEO of ReposiTrak (NASDAQ:TRAK), sold a total of 7,500 shares in late January 2026 for approximately $82,000. These stock sales occurred as the company’s share price has fallen close to its yearly low, though ReposiTrak continues to demonstrate solid financial performance. Recent quarterly revenues increased by 10%, and the compa…
Robert J. Scaringe, CEO of Rivian Automotive, sold 17,450 Class A shares worth approximately $279,761 on January 20, 2026, under an existing 10b5-1 plan. The stock sale aligns closely with recent trading prices amidst significant price volatility. Meanwhile, Rivian faces operational and strategic challenges, including a recall affecting over 19,000…
Sadri Ali, Chief Technology Officer of Airgain Inc., disposed of 4,733 shares of company stock at an average price just under $4 per share on January 20, 2026. This sale was executed under a pre-established 10b5-1 trading plan to satisfy tax withholding obligations related to vested restricted stock units. The transaction coincides with Airgain's r…
Airgain Inc's CEO Jacob Suen sold 15,993 shares to satisfy tax obligations following RSU vesting, as disclosed in a recent SEC filing. Concurrently, the company reported mixed Q3 2025 earnings, exceeding EPS forecasts but missing revenue targets, and announced a key commercial partnership to broaden deployment of its Lighthouse Smart 5G NCR offerin…
Steven E. Voskuil, Hershey Company's Senior Vice President and Chief Financial Officer, sold 1,500 shares of the company’s stock on January 20, 2026, valued at approximately $298,000. This transaction, conducted under a pre-established Rule 10b5-1 trading plan, follows a series of optimistic analyst recommendations and internal governance reforms a…
ServiceTitan, Inc. (TTAN) CFO Sherry David executed a series of stock sales totaling 998 Class A shares in late January 2026, garnering roughly $88,852. The stock has experienced year-to-date declines exceeding 17%, though recent analyst coverage underscores confidence in future profitability and growth potential. These transactions were conducted …
Ryan Cohen, the President, CEO, and Chairman of GameStop Corp., has significantly expanded his ownership stake by acquiring one million shares of the company's stock in two transactions totaling approximately $21.3 million. These purchases coincided with the company's focus on aligning executive compensation with ambitious growth targets through a …
On January 21, 2026, Entegris Inc. Senior Vice President Clinton M. Haris sold 5,830 shares of the company at $120 per share, totaling nearly $700,000. Concurrently, Haris exercised options to acquire 5,830 shares at $55.72 each. Following these transactions, Haris holds over 37,700 shares of Entegris. The company also declared a quarterly cash div…
Andrew J. Quigg, Chief Strategy Officer of Progressive Corp, sold 1,649 shares worth approximately $337,000 under a structured trading plan. The insurer recently introduced a pet insurance offering across numerous U.S. states. Analyst opinions on Progressive vary, with some upgrades balanced by lowered price targets reflecting regional rate challen…
Oragenics Inc experienced a director-led transaction involving the sale of a modest number of shares alongside the acquisition of a substantial quantity of stock options. While the company's stock has suffered a pronounced decrease over the past year, financial metrics indicate a solid liquidity position. Investors may find current valuations intri…
Jonathan S. Bauer, Chief Investment Officer of Progressive Corporation, sold over 3,000 shares in January under a pre-arranged trading plan. Concurrently, Progressive Insurance debuted a pet insurance product across 43 states and the District of Columbia. Analyst opinions on Progressive's outlook show divergence, with Barclays upgrading shares base…
Saba Capital Management, holding a substantial stake in BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT), executed the sale of 272,613 shares across two days, yielding approximately $4.19 million in proceeds. These transactions marginally lowered the firm's ownership in ECAT amidst the trust's robust dividend payout and stable market perf…
Murray Stahl, who serves as the President and Co-Portfolio Manager of RENN Fund, Inc., recently augmented his holdings by acquiring an additional 1,134 shares in the company. This transaction valued at just over $3,000 underscores Stahl's personal commitment to the fund, which boasts a favorable valuation and robust profitability with a current mar…
Guidewire Software's CEO, Michael George Rosenbaum, sold 1,200 shares of the company's stock at $156.26 per share, totaling $187,512. This transaction was carried out under a 10b5-1 trading plan. Concurrently, Guidewire has initiated a new $500 million share repurchase program following the completion of its prior buyback authorization. Investor se…
Commercial Metals Company director Dennis V. Arriola has increased his stake in the company by acquiring 2,000 shares at $74.69 each, totaling $149,380. This move comes as the company reported first-quarter fiscal 2026 results that surpassed analyst expectations on both earnings and revenue. Subsequently, Jefferies raised its price target for the s…
RenovoRx's Chief Medical Officer, Ramtin Agah, recently expanded his equity position by purchasing 10,000 shares at an average price just below $1 per share. This insider buying comes on the heels of the company's third-quarter 2025 financial report, which revealed revenues that missed analyst projections, though earnings per share aligned with mar…
Julie Andrews, CFO of Orthofix Medical Inc., has recently sold nearly 4,900 shares of the company’s stock valued at over $70,000 to cover tax obligations linked to restricted stock units. The transaction was mandated by the Compensation and Talent Development Committee with no personal discretion from Andrews. Concurrently, Orthofix reported its th…
Julie Andrews, CFO of Orthofix Medical Inc., divested 4,873 shares of the company's stock to fulfill tax withholding requirements stemming from restricted stock units. The sale, which was not at Andrews' discretion but mandated by the board committee, comes amid the firm's recent reporting of mixed third-quarter financial outcomes, with earnings pe…
